Gapping down
In reaction to disappointing earnings/guidance: CTSH -7.8%, AVXL -6.9%,L -5.9%, CFCB -3%, QTNT -1.6%
Select EU related names showing weakness: ARMH -5%, DB -5%, PUK-4.2%, SAN -3.9%, ASML -3.8%, CS -3.6%, VOD -3%
Select fan favorites trading lower: TSLA -5.3%, AMZN -4%, FB -3.7%,BABA -3.6%, PYPL -3.5%, RACE -3.5%
Select oil/gas related names showing early weakness: SDRL -9.7%, CHK-7.2%, RIG -4.5%, TOT -3.7%, BP -3.4%, RDS.A -2.7%
Other news: BCRX -64.2% ( announces results from OPuS-2 for the treatment of hereditary angioedema attacks; treatment failed to demonstrate a statistically significantly lower mean attack rate versus placebo), CTIC -50.9% (announces FDA Places Partial Clinical Hold on Pacritinib IND), CLF -5.5% (settles class action suit with Northern District of Ohio), RDUS -4% (still checking), FCX -4% (copper futures trading 1.5% lower this morning)
Analyst comments: DATA -6.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley), NVO -4.7% (downgraded to Sell from Neutral at UBS), HSBC -4.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley), AZN -3.8% (downgraded to Hold at HSBC Securities)
In reaction to disappointing earnings/guidance: CTSH -7.8%, AVXL -6.9%,L -5.9%, CFCB -3%, QTNT -1.6%
Select EU related names showing weakness: ARMH -5%, DB -5%, PUK-4.2%, SAN -3.9%, ASML -3.8%, CS -3.6%, VOD -3%
Select fan favorites trading lower: TSLA -5.3%, AMZN -4%, FB -3.7%,BABA -3.6%, PYPL -3.5%, RACE -3.5%
Select oil/gas related names showing early weakness: SDRL -9.7%, CHK-7.2%, RIG -4.5%, TOT -3.7%, BP -3.4%, RDS.A -2.7%
Other news: BCRX -64.2% ( announces results from OPuS-2 for the treatment of hereditary angioedema attacks; treatment failed to demonstrate a statistically significantly lower mean attack rate versus placebo), CTIC -50.9% (announces FDA Places Partial Clinical Hold on Pacritinib IND), CLF -5.5% (settles class action suit with Northern District of Ohio), RDUS -4% (still checking), FCX -4% (copper futures trading 1.5% lower this morning)
Analyst comments: DATA -6.3% (downgraded to Equal-Weight from Overweight at Morgan Stanley), NVO -4.7% (downgraded to Sell from Neutral at UBS), HSBC -4.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley), AZN -3.8% (downgraded to Hold at HSBC Securities)